To assess the influence of the treatment with 5-azacytidine (5-aza) on the profile of metal-containing proteins and factors of their regulation in Guerin carcinoma cells in vivo. Materials and Methods: The study was conducted on Wistar rats transplanted with wild-type Guerin carcinoma (Guerin/WT) and its strains resistant to cisplatin (Guerin/CP) or doxorubicin (Guerin/Dox). Animals were distributed in 6 groups treated with 5-aza and control animals without treatment. 5-Aza was injected by i.v. route (1 injection in 4 days at a dose of 2 mg/kg starting from the 4 th day after tumor transplantation, 4 injections in total). Ferritin levels in blood serum and tumor tissue were measured by ELISA, transferrin and free iron complexes -by low-temperature EPR, miRNA-200b, -133a and -320a levels and promoter methylation -by real-time quantitative reverse transcription polymerase chain reaction. Results: The study has shown that 5-aza treatment caused demethylation of promoter regions of fth1 and tfr1 genes in all studied Guerin carcinoma strains. 5-Aza treatment resulted in a significant decrease of ferritin levels in tumor tissue (by 32.1% in Guerin/WT strain, by 29.8% in Guerin/Dox and by 69.1% in Guerin/CP). These events were accompanied by 3.5-fold and 2-fold increase of free iron complexes levels in tumor tissue of doxorubicin and cisplatin resistant strains, respectively. Also, 5-aza treatment resulted in significantly elevated levels of miR-200b, -133a, 320a expression in tumor tissue. After 5-aza treatment, ferritin levels in blood serum of animals with Guerin/Dox were increased by 23.9%, while in Guerin/Wt and Guerin/CP they were decreased by 17 and 16%, respectively. Conclusion: Alterations of epigenetic regulation upon in vivo treatment with 5-aza change the levels of metal-containing proteins due to DNA demethylation and altered miRNA expression profiles in Guerin carcinoma cells.
�espite recent advances in understanding tumor nature� many questions remain unanswered. One of them is the possi�ility of exogenous correction of certain tumor features. Solving this pro�lem would give us radically new approaches in cancer therapy� which would make tumors more sensitive to cytostatic drugs and allow to decrease toxic side effects [�] .
One of the most promising targets� which could significantly affect tumor features� is iron meta�olism �ecause this element is a vital cofactor for many important cellular processes �energy synthesis� transcrip-tion� cell division� oxidation reactions etc.� [�] . �uring last few years it has �een shown that many features of cancer cells in vitro and tumors in vivo are associated with different aspects of iron meta�olism. In our previous works we already descri�ed the changes in this process� in particular� altered expression of different metal-containing proteins in tumor cells with different degree of malignancy and different sensitivity to cisplatin and doxoru�icin [�] . Also� we revealed that Walker-�5� carcinosarcoma showed gradual changes in the levels of different metal-containing proteins at different stages of the development of resistance to doxo-ru�icin. Those changes were o�served �oth in tumor tissue and in �lood serum of the host organism [4] .
Another pro�lem is the search for useful mechanisms to correct mentioned changes in iron meta�olism and the levels of metal-containing proteins [5] . One of the promising approaches is related to epigenetic mechanisms of regulation of protein expression� such as changes in �NA methylation patterns and miRNA expression profiles [�].
In �9�4 Czechoslovakian scientists synthesized 5-aza-�'deoxycytidine �5-azacytidine� which was a new potential chemotherapeutic drug [�] . Later other scientists discovered that mechanisms of cytotoxic action of high dose 5-azacytidine �5-aza� were �ased on its incorporation into �NA and RNA� resulting in �reaks in nucleic acid chains and cell apopto-sis� while low doses of this compound inhi�ited �NA methyltransferase activity and caused �NA hypomethylation. This demethylation activity could result in altered profile of metal-containing proteins and changed tumor phenotype [�] .
So� the aim of our study was to assess the influence of the treatment with 5-aza on the profile of metalcontaining proteins and factors of their regulation in Guerin carcinoma cells in vivo. 
MATERIALS AND METHODS

ORIGINAL CONTRIBUTION
(Guerin/Dox) (2•10 � cells per animal�. These tumor strains were o�tained from National Bank of Cell Lines and Transplanted Tumors of R.E. Kavetsky Institute of Experimental Pathology� Oncology and Radio�io-logy� National Academy of Sciences of Ukraine �Kyiv� Ukraine�. The use and care of the experimental animals have �een performed in accordance with the standard international rules of �iologic ethics and was approved �y Institutional Animal Care and Use Committee.
Animals were distri�uted in � groups ��� animals per group�: �� Guerin/WT� control; �� Guerin/WT treated with 5-aza; �� Guerin/CP� control; 4� Guerin/CP treated with 5-aza; 5� Guerin/�ox� control; 4� Guerin/�ox treated with 5-aza.
�� animals from each group received 5-aza �Gedeon-Richter� Czech Repu�lic� treatment: � injection each 4 days i/v at a dose of � mg/kg starting from the 4 th day after tumor transplantation� 4 injections in total. All of the studied parameters were measured on the �� th day after tumor transplantation.
ELISA. Ferritin levels in �lood serum and tumor tissue were measured �y automatic �iochemical and immunoenzyme analyzer Chem Well �9�� �USA� using ferritin ELISA kit �Uscer� China� according to the instruction of the manufacturer. Blood serum samples were collected and tumor homogenate was prepared and stored at −�� °C.
Low-temperature electron-paramagnetic resonance (EPR). Transferrin levels in �lood serum and tumor tissue were measured using EPR method using computerized spectrometer R-���� �Russia� at �� К� E�TA sodium salt was used as anticoagulant. Stripe width was �5�5 G� frequency -9.�5 GHz� microwave power -4� mW� amplitude modulation -��.� G� frequency modulation -��� kHz. g-Factor was calculated using standard formula: g = hν/βH, where h is Plank's constant� ν -frequency� β -Bohr's magneton� H -external magnetic field in resonance.
Apoptosis and necrosis rates were estimated using classical Annexin V/PI method as previously descri�ed [5] with the use of BeckmanCoulter EPICS ® XL Flow cytofluorimeter.
Total DNA isolation. Total �NA extraction was performed with "�NA-Sor� B" �NA Isolation Kit �Am-plisens� Russia� according to the manual� provided �y manufacturer.
Methylation-specific polymerase chain reaction (PCR) (MSP).
Bisulfite conversion involves the deamination of unmodified cytosine residues to uracil under the influence of hydrosulfite ion from water solution of sodium �isulfite. Such treatment doesn't affect 5-mC and in further amplification uracils are amplified as thymines� whereas 5-mC residues get amplified as cytosines. Bisulfite conversion was performed using EZ �NA Methylation Gold-Kit �Zymo Research� USA� according to manufacturer's protocol. Aliquots of �isulfite-modified �NA were stored at −�� ˚C and were used for MSP. MSP was performed using the standard protocols; primer sequences are availa�le in Ta�le �. TSH�B and GAP�H were used as reference control genes [9] . Table 1 . Primer sequences, used in MSP
Gene
Primer sequence Size of resulting product FTH1_M F: 5' -cga ggg ttt tta gcg gtc -3' 128 bp R: 5' -atc tct tat aac cgc gtc gac -3' FTH1_U F: 5' -gtg agg gtt ttt agt ggtt -3' 128 bp R: 5' -aat ctc tta taa cca cat caa c -3' TFR1_M F: 5' -gta gtt ggg att ata ggc gc -3' 180 bp R: 5' -taa tta cca aac gcg ata act c-3' TFR1_U F: 5' -tga gta gtt ggg att ata ggt gt -3' 180 bp R: 5' -taa tta cca aac aca ata act cac -3' Notes: FTH1_M -ferritin heavy chains, methylated promoter; FTH1_Uferritin heavy chains, unmethylated promoter; TFR1_M -transferrin receptor 1, methylated promoter; TFR1_U -transferrin receptor 1, unmethylated promoter.
PCR products were analyzed �y agarose gel electrophoresis in �.�% agarose "Low EEO� Type �-A" �Sigma� USA�. After electrophoresis the results was visualized �y ethidium �romide� photographed under UV light and evaluated �y a computer program Total-La� v�.��.
Total RNA isolation. Total RNA extraction was performed with "Ri�ozol" RNA Isolation Kit �Ampli-sens� Russia�. RNA concentration was measured with Nano�rop ����c Spectrophotometer �Thermo Scientific� USA�. Purity of isolated RNA was controlled �y analyzing the ratio of O� at ���/��� nm. RNA was dissolved in TE �uffer and stored at −�� °С.
Single-stranded c�NA was synthesized from ��� ng of total RNA� using TaqMan ® MicroRNA Kit for reverse transcription.
Real-time quantitative reverse transcription PCR (qRT-PCR).
Reaction mix for reverse transcription was prepared according to manufacturer's protocol. Reverse transcription was performed with thermal cycler "Tertsik" �"�NA Tehnologіya"� Russian Federa-tion�. qRT-PCR was performed on Applied Biosystems �9��HT Fast Real-Time PCR System using TaqMan ® MicroRNA primers and manufacturer's protocol.
Small nucleolar RNA RNU4� was used as an endogenous control for normalization of miRNA expression. Relative expression of the studied miRNAs was identified �y comparative Ct method [�] . Experiments were performed in triplicates for each line� and PCR was performed three times for each sample. Expression differences �etween the studied miRNA levels relative to control was calculated �y the formula:
Fold change = 2−ΔΔCt [8] , where ΔCt �target -control� is equal to the difference �etween threshold cycles for miRNA �target� and the threshold cycle for RNU4� �control�:
ΔCt (target -control) = Ct (target) -Ct(control); ΔΔCt = ΔCt (experiment) − ΔCt (control). Statistical analysis. Experimental data were analyzed using the Student's t-test. p-Values less than �.�5 were considered statistically significant. Statistical analysis of the o�tained data was performed using the STATISTICA �.� software.
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RESULTS AND DISCUSSION
It is known that demethylating agents� such as 5-aza� enhance the expression of oncosuppressive genes [��] . In addition to affecting methylation status of promoter CpG islands� 5-aza targets are transcription factors that are involved in the cell cycle regulation. In particular� c-Myc activates expression of the transferrin receptor � �TfR��� ferritin and iron-regulated protein � �IRP��. These proteins are important regulators of iron meta�olism in the cell� and are critical for proliferation and division of tumor cells [��] .
We� resources �https://www.e�i.ac.uk/Tools/ seqstats/em�oss_cpgplot and https://genome. ucsc.edu� were used to analyze �NA segments at a distance of �.5 k� in up-and downstream regions from the transcription start sites. We found regulatory CpG-islands in promoter regions of transferrin receptor � �tfr1� and ferritin heavy chains �fth1� genes� as well as miRNA-���a� -����� and -���a.
Thus� we decided to investigate the changes in methylation status of CpG-islands in tfr1 and fth1 gene promoter areas in Guerin carcinoma strains� wild-type and resistant to doxoru�icin and cisplatin� after the session of 5-aza-�ased therapy. We esta�lished that the development of resistance to doxoru�icin and cisplatin is accompanied �y hypomethylation of studied CpG areas �Ta�le ��. After 5-aza treatment� levels of the fth1 and tfr1 promoter methylation in all strains were almost identical pointing on their demethylation. The level of promoter methylation of transferrin receptor � gene in the sensitive and resistant to doxoru�icin strains after 5-aza treatment were identical� while in cisplatin-resistant strain it was two times higher �see Ta�le ��.
However� the level of ferritin protein in the tumor tissue under the influence of 5-aza was reduced in all strains �Fig. ��� indicating that additional regulatory mechanisms are involved in response to genome methylation changes.
Another epigenetic mechanism� responsi�le for protein expression regulation is RNA interference� in which miRNAs play the major role. miRNAs are small noncoding RNAs� which regulate the expression of proteins at post-transcriptional level. For example� the targets of oncosuppressor miRNA-���� and -���a are mRNA of heavy �FTH�� and light �FTL� chains of ferritin molecule. Together with CpG methylation of these genes� miRNA-���� and -���a regulate the presence of ferritin in the cells [��] .
It was recently shown �on heme �inding protein �GCR�� that the changes in iron �alance in cells play a key role in the maturation of different miRNAs [��]. Iron-�ound transferrin �inds to transferrin receptors � and � �TfR�� �� on a cell surface and enters the cell via endocytosis. Then divalent metal transporter � ��MT�� releases the iron into the cytoplasm� forming the "la�ile iron pool"� which can �e stored in ferritin or used �y mitochondria to synthesize heme. Heme is critical for the maturation of pre-miRNA transcripts �ecause it �inds to the processing complex� which consists of �GCR� and �rosha proteins. Another way of iron-dependent regulation is pre-miRNAs export from the nucleus to the cytoplasm� where� depending on iron levels� C-domain-�inding protein PCBP� forms active dimers. �imerized PCBP� �inds �ICER resulting in miRNA maturation. Increase of iron levels in a cell leads to PCBP� monomerization and its transition into inactive form [�4]. Measurement of free iron complexes �y EPR spectroscopy �Fig. �� showed that 5-aza treatment caused no changes in Guerin/WT cells. On the other hand� levels of free iron complexes in �oth resistant strains significantly elevated after 5-aza treatment and �ecame close to those of the sensitive strain.
Next� we have studied the effects of 5-aza on the levels of miRNA� which regulate different metal-containing proteins. We found that 5-aza treatment caused the changes in the levels of miRNA-���a� -���� and ���a in tumor cells of all studied Guerin carcinoma strains. Changes of the expression in miR-���a after demethylating agent exposition had unidirectional nature in sensitive and resistant Guerin carcinoma cells �Ta�le ��.
We determined that 5-aza treatment resulted in the increase of miR-���a and -���a levels in all three strains. Levels of miR-���� also increased in all studied strains� �ut were the most pronounced in Guerin/ CP cells. O�tained data on miRNA-���a and -���� expression were in good accordance with the data on ferritin levels in tumor tissue� mentioned a�ove. So� despite hypomethylation of its promoter� fth1 expression is silenced �y miRNAs on the post-transctriptional level.
It is known that tfr1 and mdr1 mRNAs are direct targets of miRNA-���a. Overexpression of �oth proteins is o�served in many cancer cells� resistant to different cytostatics. So� we speculate that the increase of microRNA-���a expression caused �y 5-aza� could sensitize malignant cells to anticancer drugs [�5].
�ue to constant �inding of �NMT enzymes� 5-aza causes apoptotic effect on poorly differentiated stem cells� �ut the exact mechanism of this influence is still unclear [��] . We assessed the apoptotic and necrotic rates of Guerin carcinoma cells� and it was found that in Guerin/WT the treatment with 5-aza resulted in the increased num�er of cells in a state of necrosis and apoptosis -�y ��.� and 49%� respectively� compared to untreated control. In Guerin/CP and Guerin/ �ox cells under the influence of 5-aza� the num�er of cells in a state of necrosis did not change� and the num�er of cells in a state of apoptosis increased twice �Ta�le 4�.
So� we can conclude that 5-aza treatment resulted in unidirectional changes in all studied Guerin carcinoma strains. Particularly� we o�served hypomethylation of fth1 and tfr1 promoters� and� as a result� elevation of free iron levels in tumor cells. This caused significant increase of expression of miRNAs involved in regulation of iron levels� resulting in silencing of ferritin expression and the loss of resistance to cytostatics.
These changes in tumor �ehavior were confirmed on organism level. After 5-aza treatment� in �lood serum of animals with Guerin/�ox ferritin levels were increased �y ��.9%� while in Guerin/WT and Guerin/ CP -decreased �y �� and ��%� respectively. Also� after 5-aza treatment we o�served lowering of ceruloplasmin activity �see Ta�le 4�. These results indicate that organism's iron stores are depleted �in accordance with the data on increase of free iron in tumor tissue�. �ecrease of ceruloplasmin activity in �lood serum �as we showed in our previous studies� is a nontumor marker of tumor sensitivity to chemotherapy.
So� we can conclude that of 5-aza can �e used as an exogenous modifier of the content of metalcontaining proteins �oth in tumor and in an organism. Moreover� 5-aza was capa�le to change some features of drug-resistant tumors� making them more sensitive to cytostatics �ecause of mdr1 deregulation and decrease of ceruloplasmin activity in �lood serum.
Our results demonstrated that 5-aza could �e considered as a promising agent� which can �e used in low doses in com�ination with convenient chemotherapy �especially cisplatin and doxoru�icin� to increase antitumor effects. 
